Business
Metatron To Enter The Fight Against Opioid Addiction And Updates Its Cannabis Online and Mobile App Storefront
Metatron To Enter The Fight Against Opioid Addiction And Updates Its Cannabis Online and Mobile App Storefront.
About this update from Metatron Inc
[{"type":"text","content":"\n \n \n Metatron To Enter The Fight Against Opioid Addiction And Updates Its Cannabis Online and Mobile App Storefront\n \n \nMetatron To Enter The Fight Against Opioid Addiction And Updates Its Cannabis Online and Mobile App Storefront\n \n DOVER, DE--(Marketwired - Jul 13, 2017) - Metatron (OTC PINK: MRNJ), an emerging pioneer of releasing Marijuana & CBD-related apps on iTunes and Google Play, is pleased to announce it has updated its product information to include a description of these products on its online storefront at http://www.cannaboids.com. The app is currently available on iTunes and Google Play.\n Metatron also is planning an all-out assault in the fight against opioid addiction by joining other Medical Marijuana Companies in this battle. Metatron is currently seeking all possible methods and products to add to its inventory so that addicted people can have access to alternative pain relief sources.\n \"Legal Marijuana and Medical Marijuana is being accepted as an alternative natural based medicine to fight pain and many other related diseases and illnesses already in many states and ballots are in several more seeking either legalization for recreational use or Medical Marijuana usage. We at Metatron believe this endeavor will increase shareholder value as we increase our potential market segment reach by adding Cannabis based CBD and THC medications where allowable by law,\" stated CEO Joe Riehl. More updates on the progress of this undertaking will be shared as events develop.\n According to ArcView Research and Forbes, the Californian cannabis market alone is expected to reach $2.3B by 2020, and nationally increase 700% over the same time period.\n The company is also pleased to announce a formal offer to Buzzlink, a cannabis e-commerce platform for dispensaries and consumers. Buzzlink.com will be financed partially by the issuance of preferred B series shares. For more information please visit http://metatroninc.com/series-b/.\n Metatron approved investors can acquire Series B shares in blocks of various sizes. The first round investors will receive the highest discount. Series B shares can be redeemed through the Company, are immune to reverse splits, and will convert at 1 B share to 50,000 common shares, details at http://metatroninc.com/series-b/\n Metatron is partnering up with Nutraceutical and Skin...